Literature DB >> 34848541

Structural basis for substrate specificity of heteromeric transporters of neutral amino acids.

Carlos F Rodriguez1, Paloma Escudero-Bravo2,3, Lucía Díaz4, Paola Bartoccioni2,3,5, Carmen García-Martín1, Joan G Gilabert6, Jasminka Boskovic1, Víctor Guallar6,7, Ekaitz Errasti-Murugarren8,3, Oscar Llorca9, Manuel Palacín8,3,5.   

Abstract

Despite having similar structures, each member of the heteromeric amino acid transporter (HAT) family shows exquisite preference for the exchange of certain amino acids. Substrate specificity determines the physiological function of each HAT and their role in human diseases. However, HAT transport preference for some amino acids over others is not yet fully understood. Using cryo-electron microscopy of apo human LAT2/CD98hc and a multidisciplinary approach, we elucidate key molecular determinants governing neutral amino acid specificity in HATs. A few residues in the substrate-binding pocket determine substrate preference. Here, we describe mutations that interconvert the substrate profiles of LAT2/CD98hc, LAT1/CD98hc, and Asc1/CD98hc. In addition, a region far from the substrate-binding pocket critically influences the conformation of the substrate-binding site and substrate preference. This region accumulates mutations that alter substrate specificity and cause hearing loss and cataracts. Here, we uncover molecular mechanisms governing substrate specificity within the HAT family of neutral amino acid transporters and provide the structural bases for mutations in LAT2/CD98hc that alter substrate specificity and that are associated with several pathologies.

Entities:  

Keywords:  HATs; amino acid transporters; hLAT2; structure; substrate selectivity

Mesh:

Substances:

Year:  2021        PMID: 34848541      PMCID: PMC8670485          DOI: 10.1073/pnas.2113573118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  59 in total

1.  Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.

Authors:  O Yanagida; Y Kanai; A Chairoungdua; D K Kim; H Segawa; T Nii; S H Cha; H Matsuo; J Fukushima; Y Fukasawa; Y Tani; Y Taketani; H Uchino; J Y Kim; J Inatomi; I Okayasu; K Miyamoto; E Takeda; T Goya; H Endou
Journal:  Biochim Biophys Acta       Date:  2001-10-01

2.  CHARMM-GUI Membrane Builder toward realistic biological membrane simulations.

Authors:  Emilia L Wu; Xi Cheng; Sunhwan Jo; Huan Rui; Kevin C Song; Eder M Dávila-Contreras; Yifei Qi; Jumin Lee; Viviana Monje-Galvan; Richard M Venable; Jeffery B Klauda; Wonpil Im
Journal:  J Comput Chem       Date:  2014-08-07       Impact factor: 3.376

3.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

4.  Glutamine efflux from astrocytes is mediated by multiple pathways.

Authors:  Joachim W Deitmer; Angelika Bröer; Stefan Bröer
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

5.  The structure of human 4F2hc ectodomain provides a model for homodimerization and electrostatic interaction with plasma membrane.

Authors:  Joana Fort; Laura R de la Ballina; Hans E Burghardt; Carles Ferrer-Costa; Javier Turnay; Cristina Ferrer-Orta; Isabel Usón; Antonio Zorzano; Juan Fernández-Recio; Modesto Orozco; María Antonia Lizarbe; Ignacio Fita; Manuel Palacín
Journal:  J Biol Chem       Date:  2007-08-26       Impact factor: 5.157

6.  In vitro Characterization of a small molecule inhibitor of the alanine serine cysteine transporter -1 (SLC7A10).

Authors:  Jeffrey M Brown; Lisa Hunihan; Margaret M Prack; David G Harden; Joanne Bronson; Carolyn D Dzierba; Robert G Gentles; Adam Hendricson; Rudy Krause; John E Macor; Ryan S Westphal
Journal:  J Neurochem       Date:  2013-12-10       Impact factor: 5.372

7.  CHARMM-GUI Membrane Builder for mixed bilayers and its application to yeast membranes.

Authors:  Sunhwan Jo; Joseph B Lim; Jeffery B Klauda; Wonpil Im
Journal:  Biophys J       Date:  2009-07-08       Impact factor: 4.033

8.  Cooperation of Antiporter LAT2/CD98hc with Uniporter TAT1 for Renal Reabsorption of Neutral Amino Acids.

Authors:  Clara Vilches; Emilia Boiadjieva-Knöpfel; Susanna Bodoy; Simone Camargo; Miguel López de Heredia; Esther Prat; Aida Ormazabal; Rafael Artuch; Antonio Zorzano; François Verrey; Virginia Nunes; Manuel Palacín
Journal:  J Am Soc Nephrol       Date:  2018-04-02       Impact factor: 10.121

9.  L amino acid transporter structure and molecular bases for the asymmetry of substrate interaction.

Authors:  Ekaitz Errasti-Murugarren; Joana Fort; Paola Bartoccioni; Lucía Díaz; Els Pardon; Xavier Carpena; Meritxell Espino-Guarch; Antonio Zorzano; Christine Ziegler; Jan Steyaert; Juan Fernández-Recio; Ignacio Fita; Manuel Palacín
Journal:  Nat Commun       Date:  2019-04-18       Impact factor: 14.919

10.  Topaz-Denoise: general deep denoising models for cryoEM and cryoET.

Authors:  Tristan Bepler; Kotaro Kelley; Alex J Noble; Bonnie Berger
Journal:  Nat Commun       Date:  2020-10-15       Impact factor: 14.919

View more
  1 in total

1.  Integrated AlphaFold2 and DEER investigation of the conformational dynamics of a pH-dependent APC antiporter.

Authors:  Diego Del Alamo; Lillian DeSousa; Rahul M Nair; Suhaila Rahman; Jens Meiler; Hassane S Mchaourab
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-15       Impact factor: 12.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.